May 15th 2025
Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Halo Pharma Shows Fixed-Dose Combination Products are Effective for Simplified Dosing
April 6th 2018Anthony Qu, PhD, vice president of Scientific Affairs at Halo Pharma, will give a presentation on fixed-dose combination products, drug products containing multiple active ingredients, as an effective approach for simplified dosing at CPhI North America on Wednesday, April 25, 2018 in Philadelphia, PA.
Pfizer CentreOne Senior Principal Scientist to Present on Scaling API Manufacturing
April 6th 2018On Tuesday, April 24, 2018, Evan Boswell, senior principal scientist at Pfizer CentreOne Contract Manufacturing, Pfizer CentreOne will give a presentation on scaling up the manufacturing process of active pharmaceutical ingredients at CPhI North America in Philadelphia, PA.
Colorcon and Applied DNA to Join Forces in Taggants for Pharmaceutical Traceability
April 5th 2018Colorcon Inc. and Applied DNA signed a supply agreement granting Colorcon exclusive right to use Applied DNA’s SigNature molecular tags in film coatings for solid oral dosage forms, and non-exclusive rights to use it in inks and colorants for SOD pharmaceuticals.